Cloacina

The annual accounts of Cloacina for financial year 2025 show a net loss of 73% of total assets. The 2025 annual accounts show equity of €40,618 and a net result of -€31,172. Equity is growing by about 5% per year across the filed financial years. Its solvency ranks better than 95% of 2,286 sector peers (NACE 63, financial year 2025). The company has been active since 2020 and the Belgian Official Gazette contains no insolvency or warning signals. The computed 12-month bankruptcy probability is 0.1% (very low).